Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lorbrena (lorlatinib) for ALK-Positive Metastatic Non-Small Cell Lung Cancer

Lorbrena® was discovered and developed by Pfizer. Credit: Yale Rosen.



  • Lorbrena
  • Lorbrena
  • Lorbrena

Go Top